Rising Pharma Holdings, Inc. is recalling 13,440 bottles of Cetirizine Hydrochloride Tablets USP 10 mg distributed nationwide in the United States. The tablets are imprinted with the wrong ID. Stop using the product and contact the manufacturer or your healthcare provider for guidance.
Tablet/Capsules Imprinted with Wrong ID
Consumers and healthcare providers should stop using this product immediately. Contact JB Chemicals and Pharmaceuticals Ltd or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Cetirizine hydrochloride is a non-drowsy antihistamine used to treat allergy symptoms. This recall concerns mislabeled tablets rather than an active drug safety issue.
Wrong ID imprinting can cause patients to take a different drug or dose, risking ineffective treatment or adverse reactions.
This recall is not described as part of a broader industry pattern.
Consumers may experience dosing confusion or take the wrong product. No injuries reported to date, but the labeling error poses safety and accuracy concerns.
NDC and lot numbers are printed on the bottle label and outer packaging; expiration date is also listed on the bottle.
Recall processing and any refunds or replacements will follow the recall administrator's timeline; expect updates.
Keep the bottle, packaging, and recall notices. Save correspondence with the manufacturer for refund or replacement claims.
Product: Cetirizine Hydrochloride Tablets USP 10 mg, 500 tablets per bottle. Manufacturer: Unique Pharmaceuticals Labs, a division of JB Chemicals & Pharmaceuticals, Ltd., Mumbai, India. Distributor: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC: 16571-402-50. Quantity: 13,440 bottles. Distribution: U.S. nationwide. Sold since: Unknown. Price: Unknown.
No injuries or incidents have been reported.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.
ZOLIQUEX recalled adult portable bed rails sold on Amazon after reports of entrapment and asphyxiation risk. The recall targets silver bed rails measuring 12.4 inches wide by 33.07 inches tall and weighing 7.1 pounds. The model numbers ZEX014-V1 and the Zoliquex branding appear on packaging. Stop using the product and seek a full refund by contacting ZOLIQUEX.
Vitaquest International recalled Arey Not Today iron supplements sold at retailers nationwide after determining the products do not meet the Poison Prevention Packaging Act's child-resistant packaging requirement. The noncompliant packaging creates a poisoning risk to young children if ingested. Consumers should stop using the products immediately and contact Vitaquest for a free child-resistant替换
Easymake adult portable bed rails imported by ZFZG-US are recalled on April 9, 2026. The recall cites a risk of entrapment and asphyxiation and notes the product lacks required hazard warning labels. Stop using the recalled rails immediately and contact ZFZG-US for a full refund.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Sangohe expands its 2026 recall of adult portable bed rails 504E and 504Q due to entrapment and asphyxiation risk. The recall cites noncompliance with the mandatory standard and missing warning labels. Stop using the recalled rails and pursue a full refund by contacting Sangohe.
Tuymec Minoxidil Hair Growth Kit sold on Amazon by DrHealBeauty is recalled for non-child-resistant packaging. The kit contains two black spray bottles with 5% minoxidil and BIOTIN labels. Consumers should stop using the product immediately and contact DrHealBeauty for a free empty replacement bottle with a child-resistant closure.
TecFlox recalled its Minoxidil Topical Solution hair growth serum bottles on April 2, 2026. The packaging is not child-resistant, violating the Poison Prevention Packaging Act. Consumers should stop using the product immediately, store it out of reach of children, and email TecFloxrecall@outlook.com to receive free replacement bottles. Only bottles with serum remaining will be replaced; dispose of